aav1-gamma-sarcoglycan vector
Gamma-sarcoglycanopathy
Genethongene_therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Gamma-sarcoglycanopathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
aav1-gamma-sarcoglycan vector is also rated in:
autosomal recessive limb-girdle muscular dystrophy type 2CDormant
CC
Indicative ·
47 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →